CLAIM #22667 · EMR (EMR) · 2024Q1 earnings call · Feb 7, 2024 · due Jun 30, 2029
“But right now, we're focused on executing the synergies by year 3. If we find good investment opportunities, we'll make that because I think 31% is the target we've set, and we feel pretty comfortable getting there.”
Ram Krishnan · COO
PENDING
graded after results covering Jun 30, 2029 are reported
How to check this claim
Look at: Segment EBITDA margin (or comparable profitability margin metric referenced as the '31% target')
It came true if: Reported margin >= 31%
Where: Company financial disclosures (10-K/10-Q segment reporting or investor presentations) by year 3 post-transaction
Verify independently
SEC filings for EMR ↗ · Claim quote is verbatim from the 2024Q1 earnings call.